Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.
Deborah Watson-JonesHugo Kavunga-MemboRebecca F GraisSteve AhukaNatalie RobertsW John EdmundsEdward Man-Lik ChoiChrissy H RobertsTansy EdwardsAnton CamachoShelley LeesMaarten LeyssenBart SpiessensKerstin LuhnMacaya DouoguihRichard HatchettDaniel G BauschJean-Jacques Muyembenull nullPublished in: BMJ open (2022)
NCT04152486.
Keyphrases